comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists The Role of Glucagon-Like Peptide-1 Receptor in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome GLP-1 Agonists in Cardiovascular Diseases:
Description
Gut 69, 19881997
This information is general and not medical advice
The single biggest factor
Most patients received alternative androgen-directed therapies while others received palliative radiotherapy and glucocorticoids: The authors assessed two alternate primary endpoints: (i) rPFS using the Prostate Cancer Working Group 3 (PCWG3) criteria by independent central review and (ii) OS
Leptin gene therapy improves type1 and type2 diabetes and diet-induced obesity in animal models, such as ob/ob, diet-induced obese mice, insulin-deficient type 1 diabetes mice, and insulin-dependent diabetes animals
